FeesSafety
Pluang+

Jupiter Lend launches $BLSH market on Solana, enabling token as collateral in new partnership.

Protocol Fundamentals
16 Nov 2026, 21:06 WIB
Tokenpost
View Source
Bullish
Jupiter Lend launches $BLSH market on Solana, enabling token as collateral in new partnership.

Jupiter Lend has introduced a dedicated market for the $BLSH token on the Solana blockchain, marking the first time $BLSH can be used as collateral on its platform. This move comes through a partnership between Bullish and an unnamed NYSE-listed company, announced at the Breakpoint event. This development could enhance liquidity and utility for $BLSH holders, though details about the partner company remain undisclosed.

Jupiter Lend's launch of a dedicated $BLSH market for collateral use is noted here with Pluang's market snapshot as of Nov 17, 2026 01:32 WIB: out of 50 major cryptocurrencies priced on Pluang, 27 rose and 22 fell. EOS rose 8.13% to Rp12.649 with a typical hold time of 87 days, while XNO fell 3.85% to Rp5.141 with a buy order activity of 67%. ONE declined 2.99% to Rp24 with a typical hold time of 153 days. The most notable figure is EOS's 8.13% increase.

More News

Disney Q4 outlook strong with 50%+ EPS growth and streaming as key driver

Disney Q4 outlook strong with 50%+ EPS growth and streaming as key driver

Disney's fiscal Q4 report, due November 17, is expected to show strong growth with analysts forecasting over 50% earnings per share (EPS) growth and more than 12% revenue increase. Streaming revenue rose 11% last quarter with margins hitting double d...

Company Fundamentals
Bullish
1 hour ago
Infoblox launches Australia realm on AWS for local DDI management and security.

Infoblox launches Australia realm on AWS for local DDI management and security.

Infoblox has launched a new Australia realm on Amazon Web Services (AWS) in the Sydney region, providing Australian government agencies and enterprises a local option for managing DNS, DHCP, and IP address management (DDI) with enhanced security. Thi...

Market News
Bullish
1 hour ago
European Commission approves RASONQUE for metastatic pancreatic cancer treatment

European Commission approves RASONQUE for metastatic pancreatic cancer treatment

The European Commission has approved RASONQUE (daraxonrasib), the first broad RAS-targeted oral medicine for adults with metastatic pancreatic adenocarcinoma who have had prior systemic therapy. This approval covers patients with or without identifie...

Market News
Bullish
2 hours ago
SPIE acquires Duflex to boost industrial automation and robotics in the Netherlands.

SPIE acquires Duflex to boost industrial automation and robotics in the Netherlands.

SPIE, a European leader in multi-technical services, has acquired Dutch company Duflex B.V. to enhance its industrial automation, machine building, and robotics capabilities. Duflex, with 26 employees and €8 million revenue in 2025, specializes in ta...

Company Fundamentals
Bullish
3 hours ago
Rexel repurchases 3,878 own shares at an average price of €34.67 from Nov 9-13, 2026

Rexel repurchases 3,878 own shares at an average price of €34.67 from Nov 9-13, 2026

Rexel Développement SAS disclosed that it repurchased a total of 3,878 of its own shares between November 9 and November 13, 2026. The average purchase price during this period was approximately €34.67 per share. This buyback is part of an authorized...

Company Fundamentals
Neutral
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App